RADIODIAGNOSIS AND NUCLEARTHERAPY FOR THYROID DISEASE Hesti Gunarti

  • Slides: 51
Download presentation
RADIODIAGNOSIS AND NUCLEARTHERAPY FOR THYROID DISEASE Hesti Gunarti Departemen Radiologi FK UGM/RSUP DR Sardjito

RADIODIAGNOSIS AND NUCLEARTHERAPY FOR THYROID DISEASE Hesti Gunarti Departemen Radiologi FK UGM/RSUP DR Sardjito

THYROID

THYROID

Radiodiagnosis for Thyroid Disease 1. 2. 3. 4. Ultrasonography CT Scan MRI Thyroid scintigraphy

Radiodiagnosis for Thyroid Disease 1. 2. 3. 4. Ultrasonography CT Scan MRI Thyroid scintigraphy

1. Ultrasonography (USG) � � Gray scale, color Doppler Transducer : linear frekuensi tinggi

1. Ultrasonography (USG) � � Gray scale, color Doppler Transducer : linear frekuensi tinggi (7. 5 -15. 0 MHz)

� � Ukuran normal kelenjar thyroid orang dewasa Indonesia : 4 -4, 8 cm

� � Ukuran normal kelenjar thyroid orang dewasa Indonesia : 4 -4, 8 cm x 1, 0 -1, 8 cm x 0, 8 -1, 6 cm. Berat normal : neonatus 2 -3 gram. Orang dewasa 18 -20 gram

� Normal thyroid parenchyma has a homogeneous, medium-level to high-level echogenicity that makes detection

� Normal thyroid parenchyma has a homogeneous, medium-level to high-level echogenicity that makes detection of focal cystic or hypoechoic thyroid lesions relatively easy in most cases.

Gray scale

Gray scale

Color Doppler

Color Doppler

2. CT Scan

2. CT Scan

3. MRI � Jarang dikerjakan

3. MRI � Jarang dikerjakan

4. Thyroid scintigraphy

4. Thyroid scintigraphy

PEMERIKSAAN TIROID SKENING Radiofarmaka 1. Tc-99 m Pertechnetate 2. I-131 Pengambilan citra 1. Dinamik

PEMERIKSAAN TIROID SKENING Radiofarmaka 1. Tc-99 m Pertechnetate 2. I-131 Pengambilan citra 1. Dinamik 2. Statik 3. Total body

Thyroid scintigraphy � � Thyroid nodule Congenital hypothyroidism Thyroid cancer follow up 131 I

Thyroid scintigraphy � � Thyroid nodule Congenital hypothyroidism Thyroid cancer follow up 131 I treatment

Tiroid normal dengan Te-99 m

Tiroid normal dengan Te-99 m

Struma multinoduler

Struma multinoduler

“Cold nodule” solitary

“Cold nodule” solitary

I 131

I 131

NUCLEARTHERAPY FOR THYROID DISEASE � Radioisotop : Iodine (I) 131

NUCLEARTHERAPY FOR THYROID DISEASE � Radioisotop : Iodine (I) 131

IODINE (I)-131 THERAPY FOR: 1. 2. Hyperthyroid ( Thyrotoxicosis) Thyroid cancer: 1. Papillary 2.

IODINE (I)-131 THERAPY FOR: 1. 2. Hyperthyroid ( Thyrotoxicosis) Thyroid cancer: 1. Papillary 2. Follicular 3. Mixed papillary and follicular

HYPERTHYROIDISM � � � Toxic diffuse goiter (Graves’ disease) – autoimmune Toxic adenoma –

HYPERTHYROIDISM � � � Toxic diffuse goiter (Graves’ disease) – autoimmune Toxic adenoma – more common in elderly Toxic multinodular goiter- more common in elderly Painful subacute thyroiditis – viral infection Excessive iodine intake – too much hormone production Excessive thyroid hormone replacement therapy

Hyperthyroidism: Graves’ disease

Hyperthyroidism: Graves’ disease

Diagnosis � � � Clinical history and physical examination Routine thyroid hormone function test

Diagnosis � � � Clinical history and physical examination Routine thyroid hormone function test FT 4, T 4; T 3, FT 3. Thyroid autoantibodies, antithyroid peroxidase, antithyroglobuline antibodies. Radioactive iodine uptake Radioactive thyroid scan Tc-99 m and/or I-131

SIGN AND SYMPTOMS 1. 2. 3. 4. 5. 6. 7. Central nervous system Eye,

SIGN AND SYMPTOMS 1. 2. 3. 4. 5. 6. 7. Central nervous system Eye, ear, nose, and throat Musculoskeletal Skin / hair Cardiac Gastrointestinal Genitourinary

The criteria for establishing the diagnosis 1. 2. 3. Subtle symptoms and sign of

The criteria for establishing the diagnosis 1. 2. 3. Subtle symptoms and sign of hyperthyroidism A normal FT 4 level A suppressed serum TSH level

THERAPY General therapy 1. 2. Surgical Intervention Anti thyroid drugs Specific therapy Radioactive iodine

THERAPY General therapy 1. 2. Surgical Intervention Anti thyroid drugs Specific therapy Radioactive iodine (I)-131 is the most common form of therapy in USA. It is used if the general therapy is not response or not possible to be done

INDICATION Treatment of choice: Graves’ disease • Toxic nodular goiter • 25% pt will

INDICATION Treatment of choice: Graves’ disease • Toxic nodular goiter • 25% pt will become hypothyroid 1 year later and will continue to increase yearly • If smaller doses are used, there is a higher incidence of recurrences of hyperthyroidism •

CONTRAINDICATION � � Pregnancy Breastfeeding

CONTRAINDICATION � � Pregnancy Breastfeeding

DOSES � � 185 – 553 MBq atau 5 – 15 m. Ci

DOSES � � 185 – 553 MBq atau 5 – 15 m. Ci

COMPLICATION � � Permanent hypothyroidism Prevalence rises at a rate of 2 -3% per

COMPLICATION � � Permanent hypothyroidism Prevalence rises at a rate of 2 -3% per year

� � The success rate of I-131 therapy: �May vary from 75% - 100%

� � The success rate of I-131 therapy: �May vary from 75% - 100% Side effect: �Life long hypothyroidism (Radioiodine treatment of hyperthyroidism: prognostic factors for outcome. J Clin Endocrinol Metab. 2001. Aug; 86 (8): 3611 -7)

THYROID CANCER � � Incidence: varies 1 -4/100. 000/year Histological types: � Papillary(paling �

THYROID CANCER � � Incidence: varies 1 -4/100. 000/year Histological types: � Papillary(paling � Follicular � Anaplastic sering/most case)

THYROID CANCER Papillary: The most common, usually affects women of child bearing age (CBA)

THYROID CANCER Papillary: The most common, usually affects women of child bearing age (CBA) Follicular: 30% of all cases, greater rate of recurance and metastasis Medullary: Familial, the symptoms similar to Chushing’s Syndrome Anaplastic: Giant and Spindle Cell Cancer, the most malignant form, does not response to radioiodine therapy, quickly metastasis, invades nearby structures i. e trachea, causing compression, breathing difficulties

THYROID CANCER 1. Papillary cancer: a. b. c. Not an aggressive tumor Metastasizes locally

THYROID CANCER 1. Papillary cancer: a. b. c. Not an aggressive tumor Metastasizes locally 10 -years survival time more than 90% 2. Follicular cancer: a. b. More aggressive Metastasizes via the bloodstream

PREVENTION NO KNOWN PREVENTION

PREVENTION NO KNOWN PREVENTION

SYMPTOMS � � � Enlargement of thyroid gland or neck swelling Hoarseness or changing

SYMPTOMS � � � Enlargement of thyroid gland or neck swelling Hoarseness or changing voice Cough or cough with bleeding Diarhea or constipation Very depending on the type of thyroid cancer

TESTS � Biopsy of the thyroid: � Anaplastic, � follicular, medullary, papillary US of

TESTS � Biopsy of the thyroid: � Anaplastic, � follicular, medullary, papillary US of the thyroid: � Nodule � Thyroid scan: � Cold � nodule Laryngoscopy: � Paralyzed � vocal cords Serum calcitonin: � Elevated � T 3, T 4, dexametasone supression test, CEA

Malignant follicular neoplasms

Malignant follicular neoplasms

Multicentric medullary thyroid carcinoma

Multicentric medullary thyroid carcinoma

Seorang wanita 36 th dengan benjolan pada leher THYROID SCINTIGRAPHY Cold nodule” solitary

Seorang wanita 36 th dengan benjolan pada leher THYROID SCINTIGRAPHY Cold nodule” solitary

THERAPY OF DIFFERENTIATED THYROID CANCER � � SURGICAL RESECTION RADIOTHERAPY IN MANY CASES (RADIATION

THERAPY OF DIFFERENTIATED THYROID CANCER � � SURGICAL RESECTION RADIOTHERAPY IN MANY CASES (RADIATION THERAPY WITH I-131)

RADIOIODINE THERAPY � � � � Thyroid scan: Tc-99 m and I-131 Blood routine,

RADIOIODINE THERAPY � � � � Thyroid scan: Tc-99 m and I-131 Blood routine, LFT (GOT/PT), KFT (Ur & Crea). Bone scanning, USG liver. Dosage: 100 -150 m. Ci orally. TB scan 10 days after I-131 Tx Follow-up: 2 w, 4 w, 1 m, 3 m, 6 m, and 12 m I-131 TB scan 6 m, 12 m.

RADIOIODINE THERAPY Thyroid remnant Before ablated Thyroid remnant After ablated

RADIOIODINE THERAPY Thyroid remnant Before ablated Thyroid remnant After ablated

I-131 TB SCAN 24 H AFTER TX

I-131 TB SCAN 24 H AFTER TX

IS RADIOACTIVE IODINE SAFE? � � The long term safety seems excellent No excess

IS RADIOACTIVE IODINE SAFE? � � The long term safety seems excellent No excess cancer mortality after decades of follow-up. (Long term comparative cancer mortality after use of radioiodine in treatment of hyperthyroidism a fully reported multicenter study. J Insur Med. 2001; 33 (2): 13742) � There does not appear to be any significant excess total cancer mortality in patients after radioactive iodine therapy. (JAMA 1998 ; 280: 347355. The Lancet 1999; 353 : 2111 -2115)

1. Laki-laki 48 th post operasi total thyroidectomy karena malignansi thyroid. Sisa kelenjar thyroid

1. Laki-laki 48 th post operasi total thyroidectomy karena malignansi thyroid. Sisa kelenjar thyroid yg sakit yang masih ada pada thyroid scan dengan TC-99 m 2. THYROID SCANN PRE RADIASI DAN POST RADIASI